Results of carbon ion radiotherapy in 152 patients

International Journal of Radiation Oncology Biology Physics

Volumn 58, Issue 2, 2004, Pages 631-640

  Schulz Ertner, Daniela ^a   Nikoghosyan, Anna ^b   Thilmann, Christoph ^b   Haberer, Thomas ^c   Jäkel, Oliver ^b   Karger, Christian ^b   Kraft, Gerhard ^c   Wannenmacher, Michael ^a   Debus, Jürgen ^a,b  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^c GSI HELMHOLTZZENTRUM FÜR SCHWERIONENFORSCHUNG GMBH   (Germany)

Author keywords

Adenoid cystic carcinomas; Carbon ion radiotherapy; Chondrosarcomas; Chordomas

Indexed keywords

CARBON; DOSIMETRY; IONS; PHOTONS; TOXICITY; TUMORS;

REIRRADIATION;

RADIOTHERAPY;

CARBON;

ADENOID CYSTIC CARCINOMA; ADULT; AGED; BACK; CANCER CONTROL; CANCER GRADING; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURVIVAL; CARBON ION RADIOTHERAPY; CHONDROSARCOMA; CHORDOMA; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; GERMANY; HUMAN; HUMAN TISSUE; LIGHT; MAJOR CLINICAL STUDY; PHASE 1 CLINICAL TRIAL; PHASE 2 CLINICAL TRIAL; PHOTON; PRIORITY JOURNAL; RADIATION INJURY; SACRUM; SPINE; STATISTICAL ANALYSIS; SURVIVAL TIME; TREATMENT OUTCOME; TUMOR GROWTH; TUMOR LOCALIZATION;

EID: 0742267280     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2003.09.041     Document Type: Conference Paper

References (32)

1. Castro J.R., Linstadt D.E., Bahary J.-P., et al. Experience in charged particle irradiation of tumors of the skull base 1977-1992 . Int J Radiat Oncol Biol Phys. 29:1994;647-655.
2. Tsujii H., Morita S., Miyamoto T., et al. Experiences of carbon ion radiotherapy at NIRS. Kogelnik H.D., Lukas P., Sedlmayer F. Progress in radio-oncology VII. 2002;393-405 Monduzzi Editore, Bologna, Italy.
3. Haberer T., Becher W., Schardt D., et al. Magnetic scanning system for heavy ion therapy. Nucl Instr Meth Phys Res. 330:1993;296-305.
4. Krämer M., Jäkel O., Haberer T., et al. Treatment planning for heavy ion radiotherapy Physical beam model and dose optimization . Phys Med Biol. 45:2000;3299-3317.
5. Krämer M., Scholz M. Treatment planning for heavy-ion radiotherapy Calculation and optimization of biologically effective dose . Phys Med Biol. 45:2000;3319-3330.
6. Jäkel O., Hartmann G.H., Karger C.P., et al. Quality assurance for a treatment planning system in scanned ion beam therapy. Med Phys. 27:2000;1588-1600.
7. Scholz M., Kellerer A.M., Kraft-Weyrather W., et al. Computation of cell survival in heavy ion beams for therapy. The model and its approximation. Radiat Environ Biophys. 36:1997;59-66.
8. Karger C.P., Jäkel O., Debus J., et al. Three dimensional accuracy and interfractional reproducibility of patient fixation using a stereotactic head mask system. Int J Radiat Oncol Biol Phys. 49:2001;1493-1504.
9. Lohr F., Debus J., Frank C., et al. Noninvasive patient fixation for extracranial stereotactic radiotherapy. Int J Radiat Oncol Biol Phys. 45:1999;521-527.
10. Jäkel O., Krämer M., Karger C.P., et al. Treatment planning for heavy ion radiotherapy Clinical implementation and application . Phys Med Biol. 46:2001;1101-1116.
11. Enghardt W., Debus J., Haberer T., et al. The application of PET to quality assurance of heavy-ion tumor therapy. Strahlenther Onkol. 175:(Suppl. 2):1999;33-36.
12. Kaplan E.L., Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc. 53:1958;457-481.
13. National Cancer Institute (NCI). Common toxicity criteria. Bethesda, MD: Division of Cancer Treatment, National Cancer Institute; 1988.
14. Munzenrider J.E., Liebsch N.J. Proton therapy for tumors of the skull base. Strahlenther Onkol. 175:(Suppl. II):1999;57-63.
15. Santoni R., Liebsch N., Finkelstein D.M., et al. Temporal lobe (TL) damage following surgery and high-dose photon and proton irradiation in 96 patients affected by chordomas and chondrosarcomas of the base of the skull. Int J Radiat Oncol Biol Phys. 41:1998;59-68.
16. Hug E.B., Loredo L.N., Slater J.D., et al. Proton radiation therapy for chordomas and chondrosarcomas of the skull base. J Neurosurg. 91:1999;432-439.
17. Noel G., Habrand J.L., Mammar H., et al. Combination of photon and proton radiation therapy for chordomas and chondrosarcomas of the skull base The Centre de Protonthérapie d'Orsay experience . Int J Radiat Oncol Biol Phys. 51:2001;392-398.
18. Schulz-Ertner D., Haberer T., Jäkel O., et al. Radiotherapy for chordomas and low-grade chondrosarcomas of the skull base with carbon ions. Int J Radiat Oncol Biol Phys. 53:2002;36-42.
19. Schoenthaler R., Castro J.R., Petti P.L., et al. Charged particle irradiation of sacral chordomas. Int J Radiat Oncol Biol Phys. 26:1993;291-298.
20. Berson A.M., Castro J.R., Petti P., et al. Charged particle irradiation of chordoma and chondrosarcoma of the base of skull and cervical spine The Lawrence Berkeley Laboratory experience . Int J Radiat Oncol Biol Phys. 15:1988;559-565.
21. Garden A.S., Weber R.S., Morrison W.H., et al. The influence of positive margins and nerve invasion in adenoid cystic carcinoma of the head and neck treated with surgery and radiation. Int J Radiat Oncol Biol Phys. 32:1995;619-626.
22. Regine W.F., Mendenhall W.M., Parsons J.T., et al. Radiotherapy for adenoid cystic carcinoma of the palate. Head Neck. 15:1993;241-244.
23. Vikram B., Strong E.W., Shah J.P., et al. Radiation therapy in adenoid cystic carcinoma. Int J Radiat Oncol Biol Phys. 10:1984;221-223.
24. Griffin T.W., Pajak T.F., Laramore G.E., et al. Neutron vs photon irradiation of inoperable salivary gland tumors Results of an RTOG-MRC cooperative randomized study . Int J Radiat Oncol Biol Phys. 15:1988;1085-1090.
25. Laramore G.E., Krall J.M., Griffin T.W., et al. Neutron versus photon irradiation for unresectable salivary gland tumors Final report of an RTOG-MRC randomized clinical trial. Radiation Therapy Oncology Group. Medical Research Council . Int J Radiat Oncol Biol Phys. 27:1993;235-240.
26. Saroja K.R., Mansell J., Hendrickson F.R., et al. An update on malignant salivary gland tumors treated with neutrons at Fermilab. Int J Radiat Oncol Biol Phys. 13:1987;1319-1325.
27. Schultheiss T.E., Cohen L., Mansell J. Normal tissue reactions and complications following high-energy neutron beam therapy II Complication rates adjusted for censoring . Int J Radiat Oncol Biol Phys. 18:1990;165-171.
28. Buchholz T.A., Laramore G.E., Griffin B.R., et al. The role of fast neutron radiation therapy in the management of advanced salivary gland malignant neoplasms. Cancer. 69:1992;2779-2788.
29. Debus J., Wuendrich M., Pirzkall A., et al. High efficacy of fractionated stereotactic radiotherapy of large base-of-skull meningiomas Long-term results . J Clin Oncol. 19:2001;3547-3553.
30. Pirzkall A., Debus J., Haering P., et al. Intensity modulated radiotherapy (IMRT) for recurrent, residual, or untreated skull-base meningiomas Preliminary clinical experience . Int J Radiat Oncol Biol Phys. 55:2003;362-372.
31. Milosevic M.F., Frost P.J., Laperriere N.J., et al. Radiotherapy for atypical or malignant intracranial meningioma. Int J Radiat Oncol Biol Phys. 34:1996;817-822.
32. Hug E.B., DeVries A., Thornton A.F., et al. Management of atypical and malignant meningiomas Role of high-dose, 3D-conformal radiation therapy . J Neurooncol. 48:2000;151-160.